Renal Insufficiency, ChronicEUSUREXNCT03923972
Exercise Training and Physical Rehabilitation in Patients With Chronic Kidney Disease in Europe - What is the Problem?
An observational study of Renal Insufficiency, Chronic and Kidney Failure, Chronic, run by Skane University Hospital at 2 sites in Sweden.
Trial summary
This study evaluates possible barriers to physical activity/exercise training for patients with chronic kidney disease in Europe. The study's aim is to investigate structural problems and attitudes at different levels of care. Both a systemic and individual approach are applied. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Renal Insufficiency, Chronic, Kidney Failure, Chronic, Exercise
- How many people
- 1,500 participants
- Where
- 2 sitesSweden
- Study dates
- 15 May 2019to 1 Oct 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with chronic kidney disease comprising non dialysis dependent patients with stages 4-5, patients on peritoneal or hemodialysis, after a renal transplantation, physicians and nurses involved in the treatment of these patients and the director responsible for managing the nephrology department.
Who may be able to join
- all adult patients with non-dialysis dependent chronic kidney disease, peritoneal dialysis, hemodialysis, renal transplantation
- all active physicians in the department of nephrology involved in patient care
- all active nurses in the department of nephrology involved in patient care
- all heads of nephrology departments
Who cannot join
- children
- no physical disability making it impossible to conduct exercise training
- no mental disability or language problem making it impossible to understand and fill in a questionnaire
Trial locations and contacts
2 sites in 1 country.
Evangelia Kouidi, MD, PhD contact
Sweden2 sites, 2 recruiting
- Recruiting
Hallands sjukhus
Halmstad
Karl Bjurstrom, MD, Karl.Bjurstrom@regionhalland.se
- Recruiting
Ljungby lasarett
Ljungby
Lars Ekholm, lars.ekholm@kronoberg.se
About this study
Official title: Exercise Training and Physical Rehabilitation in Patients With Chronic Kidney Disease in Europe - What is the Problem? - A European Survey Study
This study evaluates possible barriers to physical activity/exercise training for patients with chronic kidney disease in Europe. The study's aim is to investigate structural problems and attitudes at different levels of care. Both a systemic and individual approach are applied. Barriers due to health care organisation and reimbursement policies will be investigated in the health care system and at the renal unit. Perceived benefits of physical activity and personal attitudes towards a healthy lifestyle will be investigated in nephrologists and renal nurses. Patients' health related quality of life, attitudes and perceived availability will be explored.
Read the detailed description
Exercise training and physical rehabilitation in patients with chronic kidney disease in Europe - what is the problem? - A European survey study -EUSUREX (EUropean SUrvey on Renal EXercise)
Purpose Firstly, to identify potential barriers for integrating exercise training into regular therapy for patients with chronic kidney disease in different European countries.
Secondly, to use this knowledge of the importance of different barriers to promote the use of exercise training as therapy and to target the respective levels.
Thirdly, if there are obvious differences at the level of the health care system, positive examples from one country could be used as a lever in another country.
Background Lack of physical activity is common in patients with chronic kidney disease (CKD) and is a risk factor for increased mortality (1) as in the general population (2). To date there is a body of scientific evidence showing that patients with nondialysis dependent CKD, patients on maintenance dialysis and patients after renal transplantation all benefit from regular exercise training (3,4).
Many national societies worldwide recommend that exercise training be incorporated into treatment of patients with CKD. A number of qualitative and quantitative studies have highlighted various barriers to exercise training (5-12). The most commonly described barriers include patient hesitation due to feeling tired, not having time, being in pain or just being afraid to move. Other common barriers are staff related. Nurses are pressed for time and do not feel they have knowledge or competence to assist patients. Nephrologists do not ask patients about their physical activity or just do not think it is important. Some studies, albeit in general practitioners and cardiologists, have shown an association between the physicians' own level of physical activity and propensity to recommend physical activity to their patients. In a pilot study, the investigators found association between both renal physicians and nurses levels of physical activity and propensity to recommend physical training to their patients with chronic kidney disease (13).
No study has to date described possible barriers due to the health care system. These could be caused by the remuneration system, traditions pertaining to employing dedicated and specially trained physiotherapists or exercise physiologists or other causes.
There is to the investigators' knowledge no study employing a European perspective and investigating patients', physicians', nursing staff's and hospital administrators' attitudes and perception of barriers to integrating regular exercise training into routine clinical care. Nor is there any study examining the whole spectrum of chronic kidney disease, i.e comprising nondialysis dependent CKD, maintenance dialysis treatment, including both patients treated with hemodialysis and peritoneal dialysis, and after renal transplantation.
Methods Selection of participating centres with research subjects and patients A list of all Renal units for each country was sent to professor Carmine Zoccali's group with headquarters in Reggio di Calabria, where dr Giovanni Tripepi, head biostatistician of the CNR-IFC Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension Unit, randomly selected one renal unit per 4 million inhabitants.
The investigators aim is to include at least 1000 patients. If the investigators do not receive a sufficient number of replies from the patients from the centres the investigators have already contacted (all randomly selected), the investigators will make another random selection in the various countries and involve (just for the Patient questionnaire) other centres.
Construction of the questionnaires Step 1. National experts interested in the field of exercise training in patients with CKD were consulted.
Step 2. Current literature, pre-existing questionnaires and general experiences and suggestions received by various colleagues were collected and formed a basis for constructing the questionnaires.
Step 3. Five questionnaires were constructed targeting country level organization of physical rehabilitation programs as well as clinicians', nurses' and patients' perception about physical exercise and physical rehabilitation programmes.
- Country level questionnaire - general questions about physical rehabilitation opportunities at country level,
- Renal unit level questionnaire - questions about physical rehabilitation programs at the renal unit level,
- Nephrologist questionnaire - questions about how the problem is perceived by clinicians
- Nurse questionnaire - questions about how the problem is perceived by nurses
- Patient questionnaire - the SF-36 was used with added questions about how the problem is perceived by the patients.
Step 4 Questionnaires were validated for clarity and consistency of content in randomly selected units in EU countries.
Validation questions were constructed for each questionnaire. Each participating country has one or two national leaders responsible for the study.
The national leaders sent the questionnaires 2, 3 and 4 together with corresponding validation questionnaires to the heads of the randomly selected Renal units in their respective countries for validation by the head of the unit, the physicians and head nurse(s). Questionnaires 1 and 5 were validated by each country's national leader.
Step 5 After validation the questionnaires were once again sent to the national leaders for distribution to each country's randomly selected renal centres for a new evaluation to ensure that the questionnaires are clear and are consistent with content. Further refinements if necessary will be performed after which the final step of validation is completed. Finally, each national leader will translate the appropriate questionnaires as deemed necessary. The SF-36 is translated and validated in most European languages. The national leader will only need to translate the additional questions.
Distribution of questionnaires Once the questionnaires have been validated and unanimously approved, the colleagues at the various centres involved in the validation process (all randomly selected) will be asked to compile the VALIDATED Country-, Renal Unit-, Clinician-, Nurse- questionnaires and administer the Patient questionnaire to the whole (consenting) patient population at their respective centres.
Statistical evaluation The questionnaires will be sent to CNR-IFC Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension Unit in Reggio di Calabria for statistical evaluation. Data description and data analysis will be performed with parametric and non-parametric methods recommended for the analysis of questionnaires (14) by the STATA 15 statistical package.
- Keywords
- physical activity, exercise training, surveys and questionnaires, chronic kidney disease, dialysis, kidney transplantation, health care facilities
- Medical subject headings
- Renal Insufficiency, Chronic, Kidney Failure, Chronic, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patients with chronic kidney disease | Patients with non dialysis dependent chronic kidney disease stages 4-5, patients on renal replacement therapy treated with peritoneal dialysis or hemodialysis, patients after renal transplantation | |
| Nephrologists | physicians treating patients with chronic kidney disease | |
| Nephrology nurses | nurses caring for patients with chronic kidney disease | |
| heads of Nephrology departments | Medical and/or administrative directors of e nephrology department with knowledge of the healthcare system in their country |
What is being measured
The primary outcome is the main question the study is designed to answer.
Exercise prescription to patients with chronic kidney disease
Number of units with exercise prescription plans
Measured: through study completion, an average of one year
Nephrologists exercise habits
Number of nephrologists participating in regular exercise
Measured: through study completion, an average of one year
Renal nurses exercise habits
Number of renal nurses participating in regular exercise
Measured: through study completion, an average of one year
CKD patients exercise habits
Number of patients who have received prescription of exercise training
Measured: through study completion, an average of one year
Health related quality of life in patients with CKD
SF-36 quality of life questionnaire
Measured: through study completion, an average of one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Apr 2019
- Study start15 May 2019
- Primary completion1 Oct 2022 (estimated)
- Study completion1 Oct 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Renal Insufficiency, ChronicStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Skane University Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Cardenal Herrera University, Aristotle University Of Thessaloniki, Queen Margaret University, Universiteit Antwerpen, Tartu University Hospital, University of Pisa, King's College London, Sozialstiftung Bamberg, Azienda Ospedaliera Bianchi-Melacrino-Morelli
- Responsible party
- Principal investigator, Naomi Clyne, Skane University Hospital
- Investigators
- Carmine Zoccali, MD, PhD, Study chair, CNR-IFC Clinical epidemiology of renal diseases and hypertension, Reggio Cal.Naomi Clyne, MD, PhD, Study chair, Clinical Sciences, Lund, Lund University and Skåne University HospitalCarmine Zoccali, MD, PhD, Principal investigator, CNR-IFC Clinical epidemiology of renal diseases and hypertensionFrancesca Malamacci, MD, PhD, Principal investigator, Azienda Ospedaliera Bianchi-Melacrino-Morelli di Reggio CalabriaNaomi Clyne, MD, PhD, Principal investigator, Clinical Sciences, Lund, Lund University and Skåne University HospitalEvangelia Kouidi, MD, PhD, Principal investigator, Aristotle University Of ThessalonikiAmaryllis VanCraenenbroeck, MD, PhD, Principal investigator, KU LeuvenAdamasco Cupisti, MD, PhD, Principal investigator, University of Pisa
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03923972
- Sponsor's protocol ID
- EUSUREX-01
- Acronym
- EUSUREX
- Status last verified
- Oct 2021
- First submitted
- 12 Mar 2019
- Last updated
- 8 Nov 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Nov 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Exercise Training and Physical Rehabilitation in Patients With Chronic Kidney Disease in Europe - What is the Problem? - A European Survey Study
- ClinicalTrials.gov ID
- NCT03923972
- Acronym / sponsor ID
- EUSUREX / EUSUREX-01
- Keywords
- physical activity, exercise training, surveys and questionnaires, chronic kidney disease, dialysis, kidney transplantation, health care facilities
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,500 participants (estimated)
- Lead sponsor
- Skane University HospitalUniversity, hospital or other
- Collaborators
- Cardenal Herrera University, Aristotle University Of Thessaloniki, Queen Margaret University, Universiteit Antwerpen, Tartu University Hospital, University of Pisa, King's College London, Sozialstiftung Bamberg, Azienda Ospedaliera Bianchi-Melacrino-Morelli
- Study start
- 15 May 2019 (actual)
- Primary completion
- 1 Oct 2022 (estimated)
- Study completion
- 1 Oct 2022 (estimated)
- First posted
- 23 Apr 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates possible barriers to physical activity/exercise training for patients with chronic kidney disease in Europe. The study's aim is to investigate structural problems and attitudes at different levels of care. Both a systemic and individual approach are applied. Barriers due to health care organisation and reimbursement policies will be investigated in the health care system and at the renal unit. Perceived benefits of physical activity and personal attitudes towards a healthy lifestyle will be investigated in nephrologists and renal nurses. Patients' health related quality of life, attitudes and perceived availability will be explored.
Detailed description
Exercise training and physical rehabilitation in patients with chronic kidney disease in Europe - what is the problem? - A European survey study -EUSUREX (EUropean SUrvey on Renal EXercise)
Purpose Firstly, to identify potential barriers for integrating exercise training into regular therapy for patients with chronic kidney disease in different European countries.
Secondly, to use this knowledge of the importance of different barriers to promote the use of exercise training as therapy and to target the respective levels.
Thirdly, if there are obvious differences at the level of the health care system, positive examples from one country could be used as a lever in another country.
Background Lack of physical activity is common in patients with chronic kidney disease (CKD) and is a risk factor for increased mortality (1) as in the general population (2). To date there is a body of scientific evidence showing that patients with nondialysis dependent CKD, patients on maintenance dialysis and patients after renal transplantation all benefit from regular exercise training (3,4).
Many national societies worldwide recommend that exercise training be incorporated into treatment of patients with CKD. A number of qualitative and quantitative studies have highlighted various barriers to exercise training (5-12). The most commonly described barriers include patient hesitation due to feeling tired, not having time, being in pain or just being afraid to move. Other common barriers are staff related. Nurses are pressed for time and do not feel they have knowledge or competence to assist patients. Nephrologists do not ask patients about their physical activity or just do not think it is important. Some studies, albeit in general practitioners and cardiologists, have shown an association between the physicians' own level of physical activity and propensity to recommend physical activity to their patients. In a pilot study, the investigators found association between both renal physicians and nurses levels of physical activity and propensity to recommend physical training to their patients with chronic kidney disease (13).
No study has to date described possible barriers due to the health care system. These could be caused by the remuneration system, traditions pertaining to employing dedicated and specially trained physiotherapists or exercise physiologists or other causes.
There is to the investigators' knowledge no study employing a European perspective and investigating patients', physicians', nursing staff's and hospital administrators' attitudes and perception of barriers to integrating regular exercise training into routine clinical care. Nor is there any study examining the whole spectrum of chronic kidney disease, i.e comprising nondialysis dependent CKD, maintenance dialysis treatment, including both patients treated with hemodialysis and peritoneal dialysis, and after renal transplantation.
Methods Selection of participating centres with research subjects and patients A list of all Renal units for each country was sent to professor Carmine Zoccali's group with headquarters in Reggio di Calabria, where dr Giovanni Tripepi, head biostatistician of the CNR-IFC Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension Unit, randomly selected one renal unit per 4 million inhabitants.
The investigators aim is to include at least 1000 patients. If the investigators do not receive a sufficient number of replies from the patients from the centres the investigators have already contacted (all randomly selected), the investigators will make another random selection in the various countries and involve (just for the Patient questionnaire) other centres.
Construction of the questionnaires Step 1. National experts interested in the field of exercise training in patients with CKD were consulted.
Step 2. Current literature, pre-existing questionnaires and general experiences and suggestions received by various colleagues were collected and formed a basis for constructing the questionnaires.
Step 3. Five questionnaires were constructed targeting country level organization of physical rehabilitation programs as well as clinicians', nurses' and patients' perception about physical exercise and physical rehabilitation programmes.
- Country level questionnaire - general questions about physical rehabilitation opportunities at country level,
- Renal unit level questionnaire - questions about physical rehabilitation programs at the renal unit level,
- Nephrologist questionnaire - questions about how the problem is perceived by clinicians
- Nurse questionnaire - questions about how the problem is perceived by nurses
- Patient questionnaire - the SF-36 was used with added questions about how the problem is perceived by the patients.
Step 4 Questionnaires were validated for clarity and consistency of content in randomly selected units in EU countries.
Validation questions were constructed for each questionnaire. Each participating country has one or two national leaders responsible for the study.
The national leaders sent the questionnaires 2, 3 and 4 together with corresponding validation questionnaires to the heads of the randomly selected Renal units in their respective countries for validation by the head of the unit, the physicians and head nurse(s). Questionnaires 1 and 5 were validated by each country's national leader.
Step 5 After validation the questionnaires were once again sent to the national leaders for distribution to each country's randomly selected renal centres for a new evaluation to ensure that the questionnaires are clear and are consistent with content. Further refinements if necessary will be performed after which the final step of validation is completed. Finally, each national leader will translate the appropriate questionnaires as deemed necessary. The SF-36 is translated and validated in most European languages. The national leader will only need to translate the additional questions.
Distribution of questionnaires Once the questionnaires have been validated and unanimously approved, the colleagues at the various centres involved in the validation process (all randomly selected) will be asked to compile the VALIDATED Country-, Renal Unit-, Clinician-, Nurse- questionnaires and administer the Patient questionnaire to the whole (consenting) patient population at their respective centres.
Statistical evaluation The questionnaires will be sent to CNR-IFC Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension Unit in Reggio di Calabria for statistical evaluation. Data description and data analysis will be performed with parametric and non-parametric methods recommended for the analysis of questionnaires (14) by the STATA 15 statistical package.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Patients with chronic kidney disease | – | –Patients with non dialysis dependent chronic kidney disease stages 4-5, patients on renal replacement therapy treated with peritoneal dialysis or hemodialysis, patients after renal transplantation |
| Nephrologists | – | –physicians treating patients with chronic kidney disease |
| Nephrology nurses | – | –nurses caring for patients with chronic kidney disease |
| heads of Nephrology departments | – | –Medical and/or administrative directors of e nephrology department with knowledge of the healthcare system in their country |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with chronic kidney disease comprising non dialysis dependent patients with stages 4-5, patients on peritoneal or hemodialysis, after a renal transplantation, physicians and nurses involved in the treatment of these patients and the director responsible for managing the nephrology department.
Key inclusion criteria (4 listed)
- all adult patients with non-dialysis dependent chronic kidney disease, peritoneal dialysis, hemodialysis, renal transplantation
- all active physicians in the department of nephrology involved in patient care
- all active nurses in the department of nephrology involved in patient care
- all heads of nephrology departments
Key exclusion criteria (3 listed)
- children
- no physical disability making it impossible to conduct exercise training
- no mental disability or language problem making it impossible to understand and fill in a questionnaire
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Exercise prescription to patients with chronic kidney disease
Time frame: through study completion, an average of one year
Number of units with exercise prescription plans
Nephrologists exercise habits
Time frame: through study completion, an average of one year
Number of nephrologists participating in regular exercise
Renal nurses exercise habits
Time frame: through study completion, an average of one year
Number of renal nurses participating in regular exercise
CKD patients exercise habits
Time frame: through study completion, an average of one year
Number of patients who have received prescription of exercise training
Health related quality of life in patients with CKD
Time frame: through study completion, an average of one year
SF-36 quality of life questionnaire
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Nov 2021.
- Individual participant dataSharing planned: No
Related trials for Renal Insufficiency, Chronic
Active, not recruitingPhase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
RecruitingPhase 3
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Berger Disease, Bergers Disease
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruiting
Hypothermic Kidney Machine Perfusion With Omnisol
End Stage Renal Disease (ESRD), Kidney Transplant
Not yet recruiting
An Individuation Intervention to Reduce Socioeconomic Disparities in Chronic Kidney Disease Care
Chronic Kidney Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Evangelia Kouidi, MD, PhD contact
Carmine Zoccali, MD, PhD study chair
CNR-IFC Clinical epidemiology of renal diseases and hypertension, Reggio Cal.
Naomi Clyne, MD, PhD study chair
Clinical Sciences, Lund, Lund University and Skåne University Hospital
Carmine Zoccali, MD, PhD principal investigator
CNR-IFC Clinical epidemiology of renal diseases and hypertension
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Renal Insufficiency, Chronic and Kidney Failure, Chronic, run by Skane University Hospital at 2 sites in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Naomi Clyne, MD, PhD (00464617 1682, Naomi.Clyne@med.lu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Exercise prescription to patients with chronic kidney disease (time frame: through study completion, an average of one year). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2021.